Fidelity Disruptive Medicine ETF (FMED)
NASDAQ: FMED · Real-Time Price · USD
26.10
+0.27 (1.06%)
Jun 18, 2026, 4:00 PM EDT - Market closed
FMED Holdings Information
FMED is an equity ETF with a total of 74 individual holdings. The top holdings are Fidelity Securities Lending Cash Central Fund stock at 12.38%, LifeStance Health Group at 4.68%, 10x Genomics at 3.36%, UCB SA at 3.33%, and Danaher at 3.33%.
Total Holdings
74
Top 10 Percentage
40.50%
Asset Class
Equity
ETF Category
Health
Assets
41.59M
PE Ratio
39.71
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | Fidelity Securities Lending Cash Central Fund | 12.38% |
| 2 | LFST | LifeStance Health Group, Inc. | 4.68% |
| 3 | TXG | 10x Genomics, Inc. | 3.36% |
| 4 | EBR: UCB | UCB SA | 3.33% |
| 5 | DHR | Danaher Corporation | 3.33% |
| 6 | ISRG | Intuitive Surgical, Inc. | 2.81% |
| 7 | LEGN | Legend Biotech Corporation | 2.76% |
| 8 | ARGX | argenx SE | 2.66% |
| 9 | COGT | Cogent Biosciences, Inc. | 2.64% |
| 10 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.56% |
| 11 | MRNA | Moderna, Inc. | 2.42% |
| 12 | TECH | Bio-Techne Corporation | 2.38% |
| 13 | UNH | UnitedHealth Group Incorporated | 2.36% |
| 14 | TMO | Thermo Fisher Scientific Inc. | 2.26% |
| 15 | ASND | Ascendis Pharma A/S | 2.14% |
| 16 | EW | Edwards Lifesciences Corporation | 2.12% |
| 17 | KYMR | Kymera Therapeutics, Inc. | 2.09% |
| 18 | CAI | Caris Life Sciences, Inc. | 1.98% |
| 19 | HTFL | HeartFlow, Inc. | 1.92% |
| 20 | RVMD | Revolution Medicines, Inc. | 1.87% |
| 21 | XENE | Xenon Pharmaceuticals Inc. | 1.79% |
| 22 | EPA: DIM | Sartorius Stedim Biotech S.A. | 1.78% |
| 23 | PCVX | Vaxcyte, Inc. | 1.66% |
| 24 | VCYT | Veracyte, Inc. | 1.66% |
| 25 | AXSM | Axsome Therapeutics, Inc. | 1.66% |
As of Jun 15, 2026